Marshall Wace participates in Karyopharm Therapeutics financing

Marshall Wace was a participant in this common-stock and warrant private placement. The source describes new equity issuance; individual investment amounts are not disclosed. Announcement, contingent tranches and closing are distinguished in the source evidence.